Advaxis
ADXS
$0.56
Share price
4.62%
Change (1 day)
-41.58%
Change (1 year)
Categories
Operating Margin for Advaxis (ADXS)
Operating Margin as of May 2024 (TTM): -549.75%
According to Advaxis's latest financial reports and stock price the company's current Operating Margin is -549.75%. At the end of 2021 the company had an Operating Margin of -549.75%.
Operating Margin history for Advaxis from 2005 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -549.75% | -94.74% |
| 2020 | -10,442.29% | 13067.3% |
| 2019 | -79.30% | -92.77% |
| 2018 | -1,096.24% | 34.8% |
| 2017 | -813.21% | -57.31% |
| 2016 | -1,904.75% | |
| 2014 | -1,888.22% | |
| 2010 | -2,181.24% | -9068.42% |
| 2009 | 24.32% | -100.29% |
| 2008 | -8,293.45% | 177.83% |
| 2007 | -2,985.06% | 322.87% |
| 2006 | -705.91% | 111.82% |
| 2005 | -333.25% | -27.34% |
| 2004 | -458.66% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Genocea Biosciences
GNCA | -1,084.89% | 97.34% | 🇺🇸 USA |
 Inovio Pharmaceuticals INO | -17,085.40% | 3,007.85% | 🇺🇸 USA |
 Heska Corporation
HSKA | -1.35% | -99.75% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.